Literature DB >> 15735203

Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes.

Francesco Piarulli1, Annunziata Lapolla, Giovanni Sartore, Ciro Rossetti, Giuseppe Bax, Marianna Noale, Nadia Minicuci, Cristina Fiore, Lucio Marchioro, Enzo Manzato, Domenico Fedele.   

Abstract

OBJECTIVE: The aim of our study was to examine, in type 2 diabetic patients, the relationship between autoantibodies against oxidatively modified LDL (oxLDL Ab) and two indexes of atherosclerosis, intimal-medial thickness of the common carotid artery (CCA-IMT), which reflects early atherosclerosis, and the ankle-brachial index (ABI), which reflects advanced atherosclerosis. RESEARCH DESIGN AND METHODS: Thirty newly diagnosed type 2 diabetic patients, 30 type 2 diabetic patients with long duration of disease, and 56 control subjects were studied. To detect oxLDL Ab, the ImmunoLisa Anti-oxLDL Antibody ELISA was used. ABI was estimated at rest by strain-gauge plethysmography. Carotid B-mode imaging was performed on a high-resolution imaging system (ATL HDI 5000).
RESULTS: In patients with long duration of disease, IgG oxLDL Ab were significantly higher and ABI significantly lower compared with the other two groups. We found a correlation between IgG oxLDL Ab and CCA-IMT in all diabetic patients. A significant inverse correlation between IgG oxLDL Ab and ABI only in patients with long duration of disease was seen, demonstrating a close relationship between these autoantibodies and advanced atherosclerosis.
CONCLUSIONS: IgG OxLDL Ab may be markers of the advanced phase of the atherosclerotic process and the response of the immunological system to the oxLDL, which are present within atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735203     DOI: 10.2337/diacare.28.3.653

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure.

Authors:  N C Chilelli; D Cremasco; C Cosma; E Ragazzi; F Francini Pesenti; L Bonfante; A Lapolla
Journal:  Endocrine       Date:  2015-11-20       Impact factor: 3.633

2.  Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter?

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Alipasha Meysamie; Alireza Esteghamati; Omid Khalilzadeh; Fatemeh Esfahanian; Leyla Khajeali; Firouzeh Feiz
Journal:  Cell Stress Chaperones       Date:  2010-09-26       Impact factor: 3.667

3.  Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol.

Authors:  Manouchehr Nakhjavani; Omid Khalilzadeh; Leila Khajeali; Alireza Esteghamati; Afsaneh Morteza; Arsia Jamali; Sheida Dadkhahipour
Journal:  Lipids       Date:  2010-03-12       Impact factor: 1.880

4.  Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.

Authors:  Ruben Miguel Ayzin Rosoky; Nelson Wolosker; Michel Nasser; Antonio Eduardo Zerati; Magnus Gidlund; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 5.  Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances.

Authors:  Jing Zhang; Daxin Wang; Shenghu He
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 6.  Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update.

Authors:  Francesco Piarulli; Giovanni Sartore; Annunziata Lapolla
Journal:  Acta Diabetol       Date:  2012-07-05       Impact factor: 4.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.